UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

Clinical Predictive Value of the in Vitro Cell Line, Human Xenograft, and Mouse Allograft Preclinical Cancer Models

Clinical cancer research, 2003-09, Vol.9 (11), p.4227-4239

2003

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

JNCI : Journal of the National Cancer Institute, 2005-09, Vol.97 (17), p.1262-1271

2005

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

The New England journal of medicine, 2003-11, Vol.349 (19), p.1793-1802

2003

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

The New England journal of medicine, 2005-07, Vol.353 (2), p.133-144

2005

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials : The Cross Trial Safety Analysis

Circulation (New York, N.Y.), 2008-04, Vol.117 (16), p.2104-2113

2008

Link zum Volltext

Verfügbarkeit prüfen

Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group

Value in health, 2022-07, Vol.25 (7), p.1157-1164

2022

Link zum Volltext

Verfügbarkeit prüfen

Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience

JNCI : Journal of the National Cancer Institute, 2021-10, Vol.113 (10), p.1422-1428

2021

Link zum Volltext

Verfügbarkeit prüfen

Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1618-1623

2003

Link zum Volltext

Verfügbarkeit prüfen

Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1948-1955

2008

Link zum Volltext

Verfügbarkeit prüfen

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

European journal of cancer (1990), 2005, Vol.41 (2), p.280-287

2005

Link zum Volltext

Verfügbarkeit prüfen

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4674-4682

2010

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6931-6940

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1956-1964

2008

Link zum Volltext

Verfügbarkeit prüfen

A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data

Current oncology (Toronto), 2021-03, Vol.28 (2), p.1153-1160

2021

Link zum Volltext

Verfügbarkeit prüfen

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial

BMC cancer, 2019-06, Vol.19 (1), p.552-552, Article 552

2019

Link zum Volltext

Verfügbarkeit prüfen

Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2501-2507

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2006-2011

2007

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature

Clinical lymphoma, myeloma and leukemia, 2020-11, Vol.20 (11), p.e791-e800

2020

Link zum Volltext

Verfügbarkeit prüfen

Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes

Clinical trials (London, England), 2019-02, Vol.16 (1), p.14-17

2019

Link zum Volltext

Verfügbarkeit prüfen

The impact of registration of clinical trials units: The UK experience

Clinical trials (London, England), 2015-04, Vol.12 (2), p.166-173

2015

Link zum Volltext

Verfügbarkeit prüfen

Lessons Learned in the Assessment of Health-Related Quality of Life: Selected Examples From the National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 2007-11, Vol.25 (32), p.5078-5081

2007

Link zum Volltext

Verfügbarkeit prüfen

Sentinel Lymph Node Biopsy in Early Breast Cancer: Has Its Time Come?

JNCI : Journal of the National Cancer Institute, 2006-05, Vol.98 (9), p.568-569

2006

Link zum Volltext

Verfügbarkeit prüfen

Stopping trials for benefit can (sometimes) benefit patients

Journal of clinical oncology, 2008-06, Vol.26 (16), p.2787-2788

2008

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)

International journal of radiation oncology, biology, physics, 2002-11, Vol.54 (3), p.719-728

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

Englisch
(176)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Humans
(88)
Life Sciences & Biomedicine
(82)
Oncology
(59)
Female
(54)
Biological And Medical Sciences
(46)
Medical Sciences
(46)
Middle Aged
(36)
Aged
(28)
Male
(28)
Pharmacology. Drug Treatments
(26)
Adult
(22)
Clinical Trials
(22)
Breast Neoplasms - Drug Therapy
(21)
Quality Of Life
(21)
Tumors
(20)
Canada
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
General & Internal Medicine
(17)
Medicine, General & Internal
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Predictive Value of the in Vitro Cell Line, Human Xenograft, and Mouse Allograft Preclinical Cancer Models

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials : The Cross Trial Safety Analysis

Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group

Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience

Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?

Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women

Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17

Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast Cancer

A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial

Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome

Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17

Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature

Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes

The impact of registration of clinical trials units: The UK experience

Lessons Learned in the Assessment of Health-Related Quality of Life: Selected Examples From the National Cancer Institute of Canada Clinical Trials Group

Sentinel Lymph Node Biopsy in Early Breast Cancer: Has Its Time Come?

Stopping trials for benefit can (sometimes) benefit patients

Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)

Suchergebnisse filtern